Summary

“Healthcare, Regulatory and Reimbursement Landscape - Belgium”. An essential source of information and analysis on the Belgian healthcare, regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape and healthcare infrastructure.

Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research and in-house analysis by Our team of industry experts.

In 2012, Belgium had a population of 11 million. The pharmaceutical market was estimated to be worth $6.32 billion in 2013 at consumer-price level (including Value Added Tax (VAT) and excluding hospital sales) and is expected to reach $6.77 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 0.98%. The medical device market was worth approximately $2.44 billion in 2013 and is expected to reach $3.41 billion by 2020 at a CAGR of 4.9%.

These positive trends can primarily be attributed to -
- R&D investment
- A conducive regulatory environment
- Fast approval process and high-quality research, which attract companies wanting to conduct clinical trials
- Increasing burden of elderly care
- High per-capita healthcare expenditure





Scope

The report provides information on the Belgian healthcare, regulatory and reimbursement landscape, including -

- Overview of the pharmaceutical and medical device markets, including size, segmentation, and key drivers and barriers

- Profiles and SWOT analyses of the major players in the pharmaceutical and medical device markets, namely Janssen Pharmaceutica, GlaxoSmithKline, Novartis, UCB, and Ablynx; and Siemens Healthcare, Medtronic, F. Hoffmann-La Roche, Abbott Laboratories, and Essilor International

- Insightful review of the reimbursement and regulatory landscape, with details of the reimbursement process, regulatory agencies and market authorization processes for new drug and medical devices

- Detailed analysis of the Belgian political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditure

- An overview of the opportunities for and challenges to growth in the Belgian healthcare market




Reasons to buy

The report will enhance your decision-making capability and allow you to -

- Develop business strategies by understanding the trends shaping and driving the healthcare market

- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical devices market segments and companies likely to impact the healthcare market in the future

- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnerships

- Identify, understand and capitalize on the opportunities and challenges in the healthcare market




Browse complete Report on:
http://www.aarkstore.com/pharmaceuticals-healthcare/109521/healthcare-regulatory-and-reimbursement-landscape-belgium



Table of Content

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Report Guidance
3 Overview of the Pharmaceutical and Medical Device Markets
3.1 Pharmaceutical Market
3.1.1 Market Overview
3.1.2 Pharmaceutical Imports and Exports
3.1.3 Supply Channels
3.1.4 Market Segments
3.1.5 Major Therapeutic Areas
3.1.6 Major Players
3.2 Medical Device Market
3.2.1 Market Overview
3.2.2 Overview of Top Five Segments
3.2.3 Diagnostic Device Market
3.2.4 Major Players



Related Reports:

http://www.aarkstore.com/pharmaceuticals-healthcare/109493/healthcare-regulatory-and-reimbursement-landscape-austria

http://www.aarkstore.com/pharmaceuticals-healthcare/109494/healthcare-regulatory-and-reimbursement-landscape-finland

http://www.aarkstore.com/healthcare/111115/healthcare-regulatory-and-reimbursement-landscape-norway

http://www.aarkstore.com/pharmaceuticals-healthcare/109495/healthcare-regulatory-and-reimbursement-landscape-sweden




About Aarkstore Enterprise

Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers.



Contact Details:

Aarkstore Enterprise
Phone: +91 998 729 5242
Email: [email protected]
Our Website: http://www.aarkstore.com
Our Blog : http://www.aarkstore.com/blog/